Tag: university
-
Yale Univ, Organovo to Develop 3-D Print Transplant Tissue
3 December 2014. Yale University and Organovo Inc. in San Diego are collaborating on development of synthetic tissue produced on three-dimensional printers for research on transplants in humans. Financial details of the partnership were not disclosed, but Yale and Organovo say the project is funded by the Methuselah Foundation. Organovo designs and produces human tissue…
-
NIH Grant Funds Review for New Brain Cancer Diagnostics
2 December 2014. National Cancer Institute, an agency of National Institutes of Health (NIH), awarded a grant to HealthTell Inc. to validate the company’s technology for development of a simple test to diagnose brain cancers, including glioblastoma multiforme, an aggressive and malignant form of the disease. The $225,000 grant to HealthTell funds an early-stage study…
-
Genome Editing Company Licenses University Technologies
1 December 2014. Editas Medicine, a Cambridge, Massachusetts start-up, licensed technologies developed by the company’s scientific founders and others that allow for editing the human genome to create new therapies. Financial terms of the exclusive licensing deals with Harvard University, MIT, Massachusetts General Hospital, and Duke University were not disclosed. Editas Medicine, founded in 2013,…
-
Human Longevity Accessing Twins Genomic Database
13 November 2014. Human Longevity Inc., a bioinformatics and genomics company for solving age-related medical problems, is getting access to a database of genome and gut microbe samples from twins in the U.K. to provide a broader analytical base for designing new diagnostics and therapies. Financial details of the agreement between the San Diego company founded…
-
Big Data Project Seeks to Autocomplete Software Code
5 November 2014. A new project led by computer scientists at Rice University in Houston aims to apply big data analytics and data mining for software developers to generate code the same way as search engines anticipate or correct the entry of search terms. The 4 year, $11 million initiative is funded by Defense Advanced…
-
High-Speed Artery Imaging Technology in Development
5 November 2014. A process to capture high-speed three-dimensional images of plaque deposits in arteries and analyze their chemical makeup for diagnosing heart conditions is being developed by Purdue University in West Lafayette, Indiana. The team from the lab of Purdue biomedical engineer and chemist Ji-Xin Cheng, with colleagues from Indiana University School of Medicine,…
-
Patent Issued for Engineered Peptides Forming Hydrogels
4 November 2014. Bioengineers at Kansas State University received a patent for their invention of a peptide, a protein-like compound, that turns into water-based gels for a number of medical applications. U.S. Patent and Trademark Office awarded patent number 8,835,395 to Xiuzhi (Susan) Sun, professor of grain science and bioengineering at Kansas State, as well…
-
Child-Safe Coating Devised for Button Batteries
4 November 2014. Engineers and medical researchers at Massachusetts Institute of Technology and hospitals affiliated with Harvard Medical School developed a coating for small batteries that tests show could prevent poisoning when swallowed accidentally by young children. The team from the labs of Robert Langer at MIT and Jeffrey Karp at Brigham and Women’s Hospital…
-
Ebola-Marburg Vaccine Development, Testing Contract Awarded
31 October 2014. A biodefense unit of the U.S. Department of Defense awarded a contract to vaccine maker Profectus BioSciences Inc. for development and testing of a vaccine protecting against the two major Ebola strains and related Marburg viruses. The $9.5 million contract with the Baltimore company came from DoD’s Medical Countermeasure Systems-Joint Vaccine Acquisition…
-
Synthetic Blood Thinner Antidote Developed
30 October 2014. Medical and biochemical researchers at University of British Columbia in Vancouver, Canada designed a polymer antidote for heparin that in lab animals neutralizes anti-coagulant activity and appears to be well tolerated. The team led by chemistry and pathology professor Jayachandran Kizhakkedathu published its findings yesterday in the journal Science Translational Medicine (paid subscription…